Sichenzia Ross Ference LLP Represents Biotricity, Inc. in $50 Million At-The-Market Offering Facility

Press Release – New York, NY – March 23, 2022 – Sichenzia Ross Ference LLP announced today that it represented Biotricity, Inc. (NASDAQ: “BTCY”), a medical diagnostic and consumer healthcare technology company, in a $50 million At-The-Market offering facility (“ATM”).
The shares were registered on BTCY’s Registration Statement on Form S-3 (File No. 333-255544) filed with the Securities and Exchange Commission on April 27, 2021, and declared effective by the SEC on May 4, 2021, and the prospectus supplement relating to the ATM filed with the SEC on March 22, 2022.
H.C. Wainwright acted as agent for the ATM.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and David Manno, and associates Matt Siracusa and Rajiv Radia.
- Sichenzia Ross Ference Carmel LLP Represents CIMG Inc. in $10 Million Private Placement Offering - February 14, 2025
- Sichenzia Ross Ference Carmel LLP Represents Dominari Securities, LLC and Revere Securities LLC in $15 Million Initial Public Offering of Shares of Common Stock of Aureus Greenway Holdings Inc. - February 13, 2025
- Sichenzia Ross Ference Carmel LLP Represents Autozi Internet Technology (Global) Ltd. in Private Placement Offering - February 13, 2025